FDA Approved: * May 11, 1989 Pharm Company: *WATSON LABS Category:Antidepressant
Amoxapine, sold under the brand name Asendin among others, is a tricyclic antidepressant (TCAs). It is the N-demethylated metabolite of loxapine. Amoxapine first received marketing approval in the United States in 1992 (approximately 30 to 40 years after most of the other TCAs were introduced in the United States).
1 Medical uses
3 Side effects
6 Society an...
* May have multiple approval dates, manufacturers, or labelers. 1 Discussion